Clinical Trials in Cleveland

Showing 1001-1020 of 9,497 trials

A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance

NCT05102370

Study researchers think that a drug called enasidenib may help people with clonal cytopenia of undetermined significance (CCUS) because the drug blocks the mutated IDH2 protein, which may improve blood cell counts. The purpose of this study is to find out whether enasidenib is a safe and effective treatment for CCUS.

Clonal Cytopenia of Undetermined SignificanceCCUS Clonal Cytopenia of Undetermined Significance

Memorial Sloan Kettering Cancer Center4 participantsStarted Oct 2021

Rochester, Minnesota, United States • St Louis, Missouri, United States • Basking Ridge, New Jersey, United States +9 more locations

Active Not Recruiting< 1 mile

Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction

NCT01526681

This study is a registry of general use of Avance Nerve Graft and is intended to evaluate the uses, response rates, and safety of Avance Nerve Graft in the real-life clinical setting. Optional addendums 1 and 2 included in the protocol are intended to establish comparative groups and focused subgroups within the registry.

Peripheral Nerve Injuries

Axogen Corporation3,126 participantsStarted Nov 2008

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Orange, California, United States +46 more locations

A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance

Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction

Find Trials by Condition in Cleveland

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure

A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

Single Fraction Stereotactic Radiosurgery Compared With Fractionated Stereotactic Radiosurgery in Treating Patients With Resected Metastatic Brain Disease

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

Social & Contextual Impact on Children Undergoing Liver Transplantation

Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients

Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.

EvaLuate EndoVascular Treatment of Acutely Ruptured Shallow Intradural Aneurysms With the Pipeline™ Flex Embolization Device With Shield TEchnology™ (ELEVATE)

Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction